Focus on improving our planet.
Let's collaborate for sustainability &
digitalization.

Open innovation Platform for sustainability.
Find the right opportuinty and grow up your
innovation ecosystem.

Sign in/up

Search an
opportunity

Do you want to be part of innovative a sustainable project? Search for your opportunity and make your contribution to for the sustainable growth of the economy and the planet.

Tech collaborations
Joint Ventures
Licensing
Subcontracting
Investment

Express interest
Croatian academic research group offers its database of anti...
created · Updated
Deadline: Sep 19, 2022
Received 0 expressions of interest

Summary

A Croatian academic research group active in the field of high-throughput monoclonal antibodies (mAb) development for cutting-edge applications, including proteome analysis offers its collection of mAb. Additionally, the offer includes customized production of proteins. The potential application field is industry and academia worldwide, for research and experimental therapies. The center is interested in non-exclusive licensing agreements or service agreement and joint research.

Description

This higher education institution was established in Croatia in 1955. The research centre offering the technology was established in 2006, as a part of the higher education institution with focus on high-throughput monoclonal antibodies (mAb) development for cutting-edge applications, including proteome analysis. Its expertise lies in the field of in vivo immunology, regulation of innate and adaptive immunity and pathogenesis of murine cytomegalovirus (MCMV). It also disposes of several hundred hybridoma cell lines secreting mAbs to a large variety of target proteins.

The research centre is offering a database of mAbs, a collection covering proteins of Varicella-Zoster Virus (VZV), mouse cytomegalovirus (MCMV), human cytomegalovirus (HCMV) and human (mostly) and mouse lymphocytes receptors and their ligands.
The database is a collection of monoclonal antibodies (mAbs). For most of the targeted proteins, there is no other antibody available.

In addition, the offer includes customized production of proteins, monoclonal antibodies and hybridoma cell lines:
1. Expression of proteins of interest as an essential component of the monoclonal antibody (mAb) development process.
2. Multiple immunizations of Balb/c mice or specified mouse strain(s).
3. Generation of custom hybridoma cell lines stably secreting mouse mAbs specific to your target protein.
4. Large scale production of antibodies: in vitro bioreactor mAb production and purification. Antibodies' testing by different techniques.

The research centre is interested in collaborating with:
• an industry partner interested in non-exclusive licensing agreements or services agreement, preferably with an expertise in sales of biological materials
• academic institutions interested in joint fundamental research, development of research tools and reagents, innovative diagnostic and therapeutic products, with expertise in the area of immunology and virology research.

The reason why the client is interested in cooperation is expanding business internationally.

Advantages & innovations

The database represents a collection of monoclonal antibodies (mAbs). For most of the targeted proteins, there is no other antibody available. The research group continuously generates mAbs of the highest quality, which have been demanded by industrial and academic users worldwide due to their great significance in the studies of pathogenesis of viral disease. Their potential applications are also in translational research, including the characterization of diagnostic markers and experimental therapies. Since its establishment the research group has participated in more than thirty collaborative projects with prestigious research institutes, universities and biotech SMEs from SE Europe, EU and the USA.

Stage of development

Already on the market

Partner sought

The client is looking for: - an industry partner interested in non-exclusive licensing agreements or service agreement (preferably with expertise in sales of biological materials) - an academic institutions with expertise in the area of immunology and virology research for : • joint fundamental research, • development of research tools and reagents, • innovative diagnostic and therapeutic products.

Create an
opportunity

Show your project-opportunity to generate interest of potential partners or collaborators. Companies, freelancers, or research centers can meet in Nir-vana and become perfect team together!

Latest Opportunities

EIT Food Public Engagement Proof of Concepts Call for Proposals 2023,...

published
Deadline: Aug 15, 2024
Project full name: EIT Food Public Engagement Proof of Concepts Call for Proposals 2023, 2024, 2025
Project acronym: EIT Food PE PoC Call 2023, 2024, 2025
Grant agreement number: N/A
Total EU funding available: €360 000 per submission window (total for 3 rounds: €1 380 000)
By the date of the Calls’ launches a webpage will be activated at eitfood.eu/projects/public-engagement-proof-of-concepts-call

Join and create
your ecosystem

Meet and connect with experts from around the world. Generate your innovative ecosystem and interact with them thanks to the different functionalities of Nir-vana: exchange spaces, lists of opportunities, expression of interest

Gerard Amorós Figueras
Patricia Arcos
Build your project with
the best professionals
in the sector
Latest Opportunities

    EIT Food Public Engagement Proof of Concepts Call for Proposals 2023,...

    published
    Deadline: Aug 15, 2024
    Project full name: EIT Food Public Engagement Proof of Concepts Call for Proposals 2023, 2024, 2025
    Project acronym: EIT Food PE PoC Call 2023, 2024, 2025
    Grant agreement number: N/A
    Total EU funding available: €360 000 per submission window (total for 3 rounds: €1 380 000)
    By the date of the Calls’ launches a webpage will be activated at eitfood.eu/projects/public-engagement-proof-of-concepts-call
    Swedish SME in the hygiene sector produces washable re-usable absorbent underwear helping people with little leaks such as incontinence (urine escape due to bladder weakness) or other forms of leakage during periods or pregnancy. Compared to disposable products they are environmentally sustainable, less costly, providing a sense of normalisation and comfort for users. The SME is looking for sales agents, retailers, distributors interested in entering business collaboration agreements
    Company based in Sweden, is a pioneering force in digital cleaning training, specializing in e-learning for cleaners, supervisors, and clients. With a proven track record since 1994 and a recent foray into international markets, companyseeks strategic partnerships in Europe.
    Spanish company manufacturing vinegars, lemon juice, food dressings, balsamic creams and other related products in different types of containers and different formats and weights, is looking for wholesaler or distributor. Preferred channels: supermarkets, large distribution, convenience stores, hospitality services (hotels, restaurants and catering), gourmet shops and others.

The most relevant open & connected
network for sustainable business development.

Join now!

Sustainable
projects

Nir-vana wants to be the first open innovation platform focus on sustainability.

According to the EU Action Plan there is a huge need of change to a more sustainable future and to collaborate and assure to achieve the SDG.

Network
& experts

Nir-vana is the only platform integrating seamless "search and find" to the next stage of collaborating.

Get connected with experts and companies for partnering. Find trusted innovation advisors, certified by Enterprise Europe Network and build up your team of partners, companies and experts you need for your innovation.

Find public funding &
private investors

Discover potential funding opportunities for your innovation. On nir-vana you have access to national and EU funding programmes, public funding and private investors.

Get connected to consultants and advisors specialised on funding and grant preparation.